Nature:自然期刊发表亚太地区年度科研报告

2015-03-27 佚名 生物谷

最新一期的《自然》杂志汇总了亚太地区各国家科研机构在自然期刊的发文数量,并据此作出了统计报告。报告指出,仅2014年,中国的发文数量在全球范围内仅落后于美国,位于亚太国家之首。日本,韩国,澳大利亚,印度,新加坡均位列全球前20名。对于这些顶级的科研机构来说,政府的相关政策保护与科研预算的支持是保证高产出与高质量的前提条件。

对于中国来说,在过去的几十年的时间里,中国政府在科研方面提供了巨额的支持,而这些支持也换来了回报。比如,中科院系统在三大学科中均位列第一:地球与环境科学,化学,物理学。在化学方面,中科院的发文数量是位列第二名的法国科研中心的三倍。然而其它国家则没有这么幸运。日本评论家指出政府需要增加科研预算来保证该国家的科研质量。

其它一些国家在某些特定的领域具有明显的优势。比如,韩国的一半以上的文章是关于物理科学的,而印度的一般文章都与化学问题相关。与此不同,新西兰的文章则涵盖了广大学科类别。下面重点介绍亚太各国家的科研情况。


中国

不断增加的科研投入标志着中国成为世界科研领袖的决心,而结构转型也预示着中国对产研结合的兴趣。

2015年伊始,中国科学家向世界贡献了世界上最深的海洋生物照片,这是他们在利用人工操作的"蛟龙一号"深潜船作业时的成果。蛟龙一号破纪录地达到了7000米的深度,是中国海洋探索历史的里程碑式的进展。在此之后不久,中科院便与欧洲航天局达成一项合作,将于2021年启动机器人航天计划。

为了达到发达国家的科研投入,中国的科研投入在过去的十年内以每年23%的速度惊人的增长。预计到2020年,中国的科研投入将达到GDP的2.5%,而2000年仅有1%。

在发表文章方面,OECD科学,技术与产业展望两年度报告指出:中国如果按这样的势头发展下去,将会在2020年时超过美国成为全球发文量最高的国家。在去年的自然期刊汇总报告中,中国就已经仅次于美国位列第二了。虽然在总发文量上当时美国是中国的三倍,但论每个科研机构的发文数量,中国的中科院系统是位列全球第一,超过位列第二的美国哈佛大学1.5倍之多。

为了提高中国的科研产出,中国最近正在进行科研基金转型,争取将基金的使用更加透明化。另外一方面,中国也将争取加大在基础科研方面的比例。在此之前,中国的基础科研比例仅有不到5%,远低于发达国家的20%。

在刚刚召开的12届全国人民代表大会上,李克强总理指出中国的基础科研预算要增加到660亿美元,用于污染治理,超级计算机以及神经退行性疾病等方面的研究中。

然而,中国在高速发展的过程中也出现了严重的环境问题。在全球20大空气污染的城市排名中中国占有6席,而北京的空气污染指数则经常爆表。空气污染的根源是能源的开发与使用问题。一方面,如何提高化石能源的燃烧效率,尽量降低有害气体的排放,另一方面,如何开发新型能源,替代已有的化石燃料。这些问题都需要科学研究提供解决方案。


日本

预算的紧缺使得科研投入的方式至关重要,然而是否能够通过转型维持科研质量目前还是十分不明确。

近几年的日本科研界可谓悲喜交加,既有凭借蓝光二极管获得诺贝尔奖的成功,也有人工诱导干细胞伪造数据的恶劣情况。2012年,日本首相安倍晋三希望通过科研结构的调整复苏日本经济。然而日本的科研情况确实不容乐观,2015年主要科研经费相比去年下降了3.9%(约100亿美元),许多大学,包括东京大学,已经开始自筹经费完成科研计划。

为了最大化经费的使用效果,日本加强了经费管理委员会(SCTI,一个由首相负责的机构)的权利。2015年,它们选择了153个课题进行立项,主要涵盖5个主题:清洁型能源,生活水平提高,下一代基础建设,地方资源的新型产业规划,以及11年地震以后日本北方的重建工程。而由于管制太多,不少科研人员认为项目的分配不够合理。

日本是一个快速老龄化的社会。2012年已经有25%的人口步入65岁高龄,而到2060年将会达到39.9%。因此,日本急需大量相关的医药研发储备。事实上,2013年,日本的进口药物已经超过出口药物150亿美元。目前日本政府正大力推进再生医学的发展。2013年由日本科学家山中申弥研究的诱导型多能干细胞的工作获得了诺贝尔生理学与医学奖,因此他们寄希望与IPS技术带来的临床效果。然而,这一切还都无法确定。


韩国,澳大利亚,印度,新加坡等国家地区

同时,自然期刊还对上述一些国家进行了详细的解析,在此不在赘述。

原始出处:

Mike May,Herb Brody.Nature Index 2015 Asia-Pacific,26 March,2015;doi:10.1038/519S49a


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-26 doctording1

    这篇文章有一定深度

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-26 doctording1

    是一篇不错的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    自然期刊,,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    自然期刊,,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    nature好杂志,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    nature好杂志,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=59857, encodeId=c7415985ead, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59858, encodeId=0eee59858c8, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:01:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56286, encodeId=b9a456286a1, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56287, encodeId=547f5628efd, content=自然期刊,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56288, encodeId=71e15628838, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56289, encodeId=90d75628960, content=nature好杂志,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56290, encodeId=5b1f56290a5, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56291, encodeId=300456291d2, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:35:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687539, encodeId=40b8168e5394f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Sun Jul 26 04:15:00 CST 2015, time=2015-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880563, encodeId=38ee1880563fc, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Sep 18 22:15:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2015-09-18 liye789132251

相关资讯

2014年1月30日《自然》杂志文章选读

封面故事:国际晶体学年特刊 Molecular structures: The crystal century 在Max von Laue因发现X-射线衍射而获得诺贝尔奖一个世纪之后,X-射线晶体学在几乎所有科学领域都留下了自己的身影。在本期特刊中,Nature杂志以分析von Laue的方法及其派生方法所产生影响的方式来纪念“国际晶体学年”

《自然》:2015年十大科学热点领域

《自然》杂志日前对2015年诸多科学领域的动向进行了展望。 粒子加速器 长久的等待已经结束:在关闭两年后,大型强子对撞机(LHC)将于今年3月重启。位于瑞士日内瓦附近的CERN下属欧洲粒子物理实验室的这部机器将用13万亿电子伏特的碰撞——几乎是当前纪录的2倍——开始自己的新生。科学家希望这些额外的火力能够帮助对撞机找到可供填补粒子物理标准模型缺口的未知现象。如果升级后的LHC不能找到流行的超对称性

《自然》出版集团和德国Springer合并 成为全球领先

根据来自《自然》网站的报道,自然出版集团和德国Springer合并,这次合并使该公司的杂志数量超过将产生世界拥有杂志最多的出版公司Elsevier (3,057),成为拥有学术杂志最多的出版集团。 自然集团是伦敦的麦克米伦科学和教育公司,虽然这个公司的规模比较小,但该公司旗下拥有《自然》、自然子刊和《科学美国人》等众多高水平期刊,在国际学术出版行业有非常重要的地位。Springer是德国柏林的科

2014年2月6日《自然》杂志文章选读

封面故事:水分供应情况在决定亚马逊流域碳平衡中所起作用 Drought sensitivity of Amazonian carbon balance revealed by atmospheric measurements 本期封面所示为巴西Acre州Senador Guiomard市日出时的一棵坚果树。我们对陆地碳收支对气候异常的敏感性的

小保方晴子《自然》论文被呼吁撤回

日本理化学研究所发育生物学中心的小保方晴子团队所发表的两篇令科学界震惊的文章,在发表不足40天后被呼吁撤回。呼吁者包括其中一篇文章的共同作者。该两篇文章声称能够通过简单的酸浴刺激已经分化哺乳动物细胞重新回到胚胎状态,这种细胞称为STAP细胞。 该文章发表于1月30号,而仅仅在发表后的几周内,该文章被指责学术不端以及明显使用与已发表文章重复的图片。很多科学家也表示,他们无法通过小保方晴子团

《自然》网站评出2013年受欢迎十大故事

科学家在俄罗斯西伯利亚的丹尼索瓦洞穴中首次挖掘出丹尼索瓦人的遗骸。    12月16日,英国《自然》杂志网站公布了本年度最受读者欢迎的《自然》故事的评选结果,包括病毒大到可以同细菌相“PK”;历时69年才完成的实验以及我们的宇宙如何在一个四维恒星的崩溃中形成等等。   一、12月10日:《模拟支持宇宙全息图理论》   1997年,